PT-141 Dosage Guide for Researchers: Protocols, Reconstitution & Storage

Overview

PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist used in research for studying sexual function pathways, melanocortin system biology, and CNS arousal mechanisms.

> Research Use Only: PT-141 is sold exclusively for in-vitro and preclinical laboratory research. It is not intended for human or animal therapeutic use outside of approved clinical contexts.

Reconstitution Protocol

PT-141 is supplied as a lyophilized (freeze-dried) powder. Standard reconstitution:

1. Allow the vial to equilibrate to room temperature before opening
2. Inject bacteriostatic water slowly along the vial wall
3. Gently swirl (do not vortex or shake) until fully dissolved
4. Solution should be clear and colorless; discard if cloudy or particulate

Typical reconstitution concentration: 1–10 mg/mL depending on study design

Dosing Ranges in Published Research

| Study Model | Route | Dose Range | Reference | |---|---|---|---| | Male rat sexual behavior | SC | 0.1–1 mg/kg | Molinoff et al., 2003 | | Female rat solicitation behavior | SC | 0.3–3 mg/kg | Pfaus et al., 2004 | | Human clinical (erectile dysfunction) | Intranasal | 4–20 mg | Diamond et al., 2004 | | Human clinical (HSDD) | SC auto-injector | 1.75 mg | FDA-approved Vyleesi dose | | In vitro MC4R binding assays | In vitro | 1–100 nM | Shadiack et al., 2007 |

Storage Conditions

- Lyophilized powder: Store at -20°C, protected from light; stable for 24+ months - Reconstituted solution: Store at 2–8°C; use within 28 days - Avoid repeated freeze-thaw cycles - PT-141 is sensitive to oxidation; minimize air exposure after reconstitution

Study Design Considerations

- Behavioral endpoints: Mount latency, mount frequency, intromission latency/frequency, ejaculation latency, and post-ejaculatory interval - CNS vs. peripheral effects: PT-141's primary mechanism is central (hypothalamic MC4R), but peripheral cardiovascular effects (transient blood pressure elevation) should be monitored - Sex differences: PT-141 has distinct behavioral effects in male vs. female rodent models - Receptor selectivity controls: MC3R/MC4R knockout models or selective antagonists (e.g., SHU9119) are useful controls

---

This guide is for scientific reference only. All compounds are for research use only and not for human or animal consumption.

See Also: PT-141 Research Overview · PT-141 vs Melanotan II Research Comparison · Peptide Reconstitution Guide